Systematic review evaluates cancer risks associated with autologous fat grafting in breast surgery, suggesting the need for careful consideration.
Introduction: Autologous fat grafting (AFG) is widely used in breast surgery, yet concerns regarding the oncological safety of adipose-derived stem cells persist. This review evaluates clinical evidence focusing on cancer recurrence and new primary tumor risks.
No takes yet. Share an insight, caveat, or question.
Martain P.J. Loonen (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: